BIOTEST AG ST O.N./ DE0005227201 /
| 2024-04-15 10:55:27 AM | Chg. - | Volume | Bid9:06:12 AM | Ask9:06:12 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 41.400EUR | - | 30 Turnover: 1,242 |
41.400Bid Size: 30 | 41.800Ask Size: 30 | 1.63 bill.EUR | 0.10% | - |
Assets
|
2008 IFRS in mill. EUR |
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 229.9000 | 232 | 230.7000 | 234.9000 | 243 | ||||||
| Intangible Assets | 73.8000 | 66.7000 | 64.9000 | 62.8000 | 54.6000 | ||||||
| Long-Term Investments | .2000 | .2000 | 19.3000 | 4.7000 | .2000 | ||||||
| Fixed Assets | 312.6000 | 308.2000 | 323.4000 | 312.8000 | 314.9000 | ||||||
| Inventories | 156.6000 | 170.3000 | 148.7000 | 153 | 184.2000 | ||||||
| Accounts Receivable | 94 | 96 | 98.3000 | 121 | 96.1000 | ||||||
| Cash and Cash Equivalents | 8.1000 | 6.7000 | 18.5000 | 83.2000 | 57.2000 | ||||||
| Current Assets | 279.5000 | 325.3000 | 308.9000 | 370 | 349 | ||||||
| Total Assets | 592 | 633.5000 | 632.3000 | 682.8000 | 682.3000 | ||||||
Liabilities
|
2008 IFRS in mill. EUR |
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 48.7000 | 40.6000 | 42.8000 | 34.7000 | 47.4000 | ||||||
| Long-term debt | 166.6000 | 153.7000 | 132.2000 | 101.3000 | 71 | ||||||
| Liabilities to Banks | 194.8000 | 204.5000 | 161.1000 | 139 | 112.4000 | ||||||
| Provisions | 34.1000 | 39.9000 | 34.8000 | 43.2000 | 35.6000 | ||||||
| Liabilities | 338.7000 | 363.6000 | 324.7000 | 336.1000 | 312.9000 | ||||||
| Share Capital | 30 | 30 | 30 | 30 | 30 | ||||||
| Total Equity | 248.9000 | 264.8000 | 301.6000 | 346.6000 | 369.3000 | ||||||
| Minority Interests | 4.4000 | 5.1000 | 6 | .1000 | .1000 | ||||||
| Total liabilities equity | 592 | 633.5000 | 632.3000 | 682.8000 | 682.3000 | ||||||
Income Statement
|
2008 IFRS in mill. EUR |
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 423 | 440.2000 | 412.5000 | 422 | 440 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 55.6000 | 61.5000 | 42.9000 | 41.6000 | 44.7000 | ||||||
| Interest Income | - | - | - | -13.5000 | -9.2000 | ||||||
| Income Before Taxes | 40.5000 | 49 | 28.5000 | 28.6000 | 36.5000 | ||||||
| Income Taxes | 12.4000 | 17.1000 | 8.8000 | 9.9000 | 13.4000 | ||||||
| Minority Interests Profit | -2.4000 | -3.9000 | -2.5000 | -1.8000 | 0.0000 | ||||||
| Net Income | 25.7000 | 28 | 36.9000 | 46.4000 | 33.4000 | ||||||
Per Share
Cash Flow
|
2008 IFRS in mill. EUR |
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 34.5000 | 32.7000 | 77.8000 | 72.3000 | 34.7000 | ||||||
| Cash Flow from Investing Activities | -33.1000 | -39.8000 | -16.8000 | 22 | -29.3000 | ||||||
| Cash Flow from Financing | -2.3000 | 6.8000 | -48.3000 | -30.7000 | -31.4000 | ||||||
| Decrease / Increase in Cash | -.9000 | -1.3000 | 12.7000 | 63.6000 | -26 | ||||||
| Employees | 1,952 | 1,834 | 1,721 | 1,774 | 1,870 | ||||||
